发明名称 |
COMBINATION OF BREXPIPRAZOLE AND NALMEFENE AND USE THEREOF FOR TREATING SUBSTANCE-RELATED DISORDERS |
摘要 |
A medicament comprising (I) brexpiprazole or a pharmaceutically acceptable salt thereof, and (II) nalmefene or a pharmaceutically acceptable salt thereof in combination, wherein brexpiprazole or a pharmaceutically acceptable salt thereof, and nalmefene or a pharmaceutically acceptable salt thereof are contained in a single preparation, or a pharmaceutical composition containing brexpiprazole or a pharmaceutically acceptable salt thereof and a pharmaceutical composition containing nalmefene or a pharmaceutically acceptable salt thereof are formulated for use in combination. The medicament is used for the prophylaxis or treatment of a substance-related disorder, preferably an alcohol-related disorder. |
申请公布号 |
EP3134090(A1) |
申请公布日期 |
2017.03.01 |
申请号 |
EP20150723775 |
申请日期 |
2015.04.22 |
申请人 |
Otsuka Pharmaceutical Co., Ltd.;H. Lundbeck A/S |
发明人 |
MAEDA, Kenji;NAKAMURA, Mai |
分类号 |
A61K31/485;A61K31/496;A61P25/30;A61P25/32 |
主分类号 |
A61K31/485 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|